Genedx Holdings 's (WGS) Outlook - CSIMarket
CSIMarket
 
Genedx Holdings Corp   (NASDAQ: WGS)
 



  Genedx Holdings Corp Outlook

On February 20 2024 the Genedx Holdings Corp provided following guidance

During the fourth quarter of 2023, GeneDx Holdings Corp. saw significant growth in revenue, with total revenue reaching a record high. The company's performance in 2023 was strong, with an increase in genetic testing volume and continued expansion of its test menu.

For the full year of 2023, GeneDx Holdings Corp. reported robust financial results, with revenue exceeding expectations. The company's continued focus on innovation and investment in technology has allowed it to maintain its position as a leader in genetic testing.

Looking ahead to 2024, GeneDx Holdings Corp. issued guidance for the full year, projecting continued growth and expansion. The company anticipates further increases in genetic testing volume and revenue as it continues to invest in research and development.

Overall, GeneDx Holdings Corp. is optimistic about its future prospects and is confident in its ability to drive continued growth and success in the genetic testing market.

On February 1 2024 the Genedx Holdings Corp provided following guidance

The financial results for the fourth quarter of 2023 will be announced by GeneDx on Tuesday, February 20, 2024. The management of GeneDx will also conduct a conference call at 4:30 p.m. Eastern Time on the same day to discuss the results of 2023 and provide guidance for the full year of 2024.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.